Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study
Background: Esophageal neuroendocrine neoplasms (E-NENs) are a rare and poorly reported subtype of esophageal carcinoma. We analyzed the differences in clinicopathological features, prognosis, and tumor-infiltrating lymphocytes (TILs) between E-NENs and esophageal squamous cell carcinoma (ESCC). Met...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/6/1732 |
_version_ | 1797613001156591616 |
---|---|
author | Long Zhang Boyao Yu Zhichao Liu Jinzhi Wei Jie Pan Chao Jiang Zhigang Li |
author_facet | Long Zhang Boyao Yu Zhichao Liu Jinzhi Wei Jie Pan Chao Jiang Zhigang Li |
author_sort | Long Zhang |
collection | DOAJ |
description | Background: Esophageal neuroendocrine neoplasms (E-NENs) are a rare and poorly reported subtype of esophageal carcinoma. We analyzed the differences in clinicopathological features, prognosis, and tumor-infiltrating lymphocytes (TILs) between E-NENs and esophageal squamous cell carcinoma (ESCC). Methods: A total of 3620 patients who underwent esophagectomy were enrolled retrospectively. The study cohort was divided into two groups (E-NENs and ESCC) through propensity-score matching, and the prognosis and TILs were compared between the two groups. The TILs were assessed using tumor specimens (including six cases of ESCC, six cases of neuroendocrine carcinomas [NECs], and six cases of mixed neuroendocrine–non-neuroendocrine neoplasms [MiNENs]). Results: E-NENs accounted for 3.0% (107/3620) of cases, among which there were just 3 neuroendocrine tumor cases, 51 NEC cases, and 53 MiNENs cases. After matching, esophageal neuroendocrine carcinomas (E-NECs) showed both poorer 5-year overall survival (OS; 35.4% vs. 54.8%, <i>p</i> = 0.0019) and recurrence-free survival (RFS; 29.3% vs. 48.9%, <i>p</i> < 0.001) compared with ESCC. However, the differences were not prominent in the subgroup with stage I. No significant survival benefit was observed for E-NECs with multimodal therapy. Multivariate analysis demonstrated that E-NECs are an independent risk factor for OS and RFS. In the exploratory analysis, E-NECs were associated with less infiltration of immune cells compared with ESCC. Conclusion: E-NECs are significantly associated with a poorer prognosis than ESCC except for early-stage disease. The fewer TILs within the tumor microenvironment of E-NECs compared with ESCC results in weaker anti-tumor immunity and may lead to a poorer prognosis. |
first_indexed | 2024-03-11T06:48:46Z |
format | Article |
id | doaj.art-901759681e3d4562b8cd4e666b81d92a |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-11T06:48:46Z |
publishDate | 2023-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-901759681e3d4562b8cd4e666b81d92a2023-11-17T10:06:26ZengMDPI AGCancers2072-66942023-03-01156173210.3390/cancers15061732Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching StudyLong Zhang0Boyao Yu1Zhichao Liu2Jinzhi Wei3Jie Pan4Chao Jiang5Zhigang Li6Department of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaDepartment of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaBackground: Esophageal neuroendocrine neoplasms (E-NENs) are a rare and poorly reported subtype of esophageal carcinoma. We analyzed the differences in clinicopathological features, prognosis, and tumor-infiltrating lymphocytes (TILs) between E-NENs and esophageal squamous cell carcinoma (ESCC). Methods: A total of 3620 patients who underwent esophagectomy were enrolled retrospectively. The study cohort was divided into two groups (E-NENs and ESCC) through propensity-score matching, and the prognosis and TILs were compared between the two groups. The TILs were assessed using tumor specimens (including six cases of ESCC, six cases of neuroendocrine carcinomas [NECs], and six cases of mixed neuroendocrine–non-neuroendocrine neoplasms [MiNENs]). Results: E-NENs accounted for 3.0% (107/3620) of cases, among which there were just 3 neuroendocrine tumor cases, 51 NEC cases, and 53 MiNENs cases. After matching, esophageal neuroendocrine carcinomas (E-NECs) showed both poorer 5-year overall survival (OS; 35.4% vs. 54.8%, <i>p</i> = 0.0019) and recurrence-free survival (RFS; 29.3% vs. 48.9%, <i>p</i> < 0.001) compared with ESCC. However, the differences were not prominent in the subgroup with stage I. No significant survival benefit was observed for E-NECs with multimodal therapy. Multivariate analysis demonstrated that E-NECs are an independent risk factor for OS and RFS. In the exploratory analysis, E-NECs were associated with less infiltration of immune cells compared with ESCC. Conclusion: E-NECs are significantly associated with a poorer prognosis than ESCC except for early-stage disease. The fewer TILs within the tumor microenvironment of E-NECs compared with ESCC results in weaker anti-tumor immunity and may lead to a poorer prognosis.https://www.mdpi.com/2072-6694/15/6/1732neuroendocrine neoplasmsesophageal carcinomatumor-infiltrating lymphocytesclinicopathological featuresprognosisimmunotherapy |
spellingShingle | Long Zhang Boyao Yu Zhichao Liu Jinzhi Wei Jie Pan Chao Jiang Zhigang Li Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study Cancers neuroendocrine neoplasms esophageal carcinoma tumor-infiltrating lymphocytes clinicopathological features prognosis immunotherapy |
title | Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study |
title_full | Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study |
title_fullStr | Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study |
title_full_unstemmed | Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study |
title_short | Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study |
title_sort | analysis of the clinicopathological characteristics prognosis and lymphocyte infiltration of esophageal neuroendocrine neoplasms a surgery based cohort and propensity score matching study |
topic | neuroendocrine neoplasms esophageal carcinoma tumor-infiltrating lymphocytes clinicopathological features prognosis immunotherapy |
url | https://www.mdpi.com/2072-6694/15/6/1732 |
work_keys_str_mv | AT longzhang analysisoftheclinicopathologicalcharacteristicsprognosisandlymphocyteinfiltrationofesophagealneuroendocrineneoplasmsasurgerybasedcohortandpropensityscorematchingstudy AT boyaoyu analysisoftheclinicopathologicalcharacteristicsprognosisandlymphocyteinfiltrationofesophagealneuroendocrineneoplasmsasurgerybasedcohortandpropensityscorematchingstudy AT zhichaoliu analysisoftheclinicopathologicalcharacteristicsprognosisandlymphocyteinfiltrationofesophagealneuroendocrineneoplasmsasurgerybasedcohortandpropensityscorematchingstudy AT jinzhiwei analysisoftheclinicopathologicalcharacteristicsprognosisandlymphocyteinfiltrationofesophagealneuroendocrineneoplasmsasurgerybasedcohortandpropensityscorematchingstudy AT jiepan analysisoftheclinicopathologicalcharacteristicsprognosisandlymphocyteinfiltrationofesophagealneuroendocrineneoplasmsasurgerybasedcohortandpropensityscorematchingstudy AT chaojiang analysisoftheclinicopathologicalcharacteristicsprognosisandlymphocyteinfiltrationofesophagealneuroendocrineneoplasmsasurgerybasedcohortandpropensityscorematchingstudy AT zhigangli analysisoftheclinicopathologicalcharacteristicsprognosisandlymphocyteinfiltrationofesophagealneuroendocrineneoplasmsasurgerybasedcohortandpropensityscorematchingstudy |